ロード中...
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
In modern vaccines, adjuvants can be sophisticated immunological tools to promote robust and long-lasting protection against prevalent diseases. However, there is an urgent need to improve immunogenicity of vaccines in order to protect mankind from life-threatening diseases such as AIDS, malaria or,...
保存先:
| 出版年: | Vaccines (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565252/ https://ncbi.nlm.nih.gov/pubmed/32971761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030554 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|